top of page

Medicare Part D Premiums on the Rise












This month, my newsletter explores the following topics:

 

2024 promises to be a year characterized by change driven by global and national events. Being prepared for such change – and the opportunities that come with it – can make 2024 a remarkably successful year. Don’t hesitate to contact me if I can help you plan for what’s to come in the days and months ahead.

 

Opinion: The Moment I Realized We’re Saving Too Much For Retirement

Bill Perkins, entrepreneur and hedge fund manager, shares how rethinking your retirement strategy can lead to a richer, more experience-filled life guided by real-life examples and poignant reflections.

 

Retirees Face Significantly Higher Medicare Part D Prescription Drug Premiums In 2024. What To Know

The 2025 implementation of a law limiting how much Medicare enrollees pay for prescription drugs is leading to some substantially higher Medicare Part D premiums in 2024.

 

Mortgage Rates Drop To Lowest Levels Since August

The trend toward lower mortgage rates is influenced by Federal Reserve policies and their impact on home affordability. This can provide key insights for potential homebuyers navigating the current housing market.

 

The Little-Known Retirement Savings Hack High Earners Must Know About

High earners take note: the mega backdoor Roth offers a unique opportunity to enhance your tax-advantaged savings, blending smart financial strategy with practical insights for those looking to secure a more prosperous retirement.

 

 

Michael M. Silverman is a Financial Representative of The Guardian Life Insurance Company of America, New York, NY.  Silver Lining Insurance Agency, Inc. is not an affiliate or subsidiary of Guardian.

 

Links to external sites are provided for your convenience in locating related information and services. Guardian, its subsidiaries, agents, and employees expressly disclaim any responsibility for and do not maintain, control, recommend, or endorse third-party sites, organizations, products, or services, and make no representation as to the completeness, suitability, or quality thereof.

 

2024-166824 Exp. 1/31

 

Commentaires


bottom of page